相关实验视频
Updated: Mar 20, 2026

08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
1.1K
2型糖尿病肥胖患者的腹部代谢手术与传统医学治疗:5年随机对照试验
Geltrude Mingrone1, Simona Panunzi2, Andrea De Gaetano2
1Department of Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy; Diabetes and Nutritional Sciences, King's College London, London, UK.
Lancet (London, England)
|September 16, 2015
概括
与医疗治疗相比,减肥手术显著改善了肥胖患者的长期2型糖尿病缓解. 由于手术后高血糖可能复发,建议继续监测.
科学领域:
- 代谢手术
- 内分泌学
- 糖尿病管理
背景情况:
- 腹部外科手术对2型糖尿病有短期的疗效,但长期的结果需要进一步研究.
- 肥胖和2型糖尿病的治疗往往需要探索先进的治疗方式.
- 关于手术治疗与传统治疗糖尿病患者的5年疗效的数据有限.
研究的目的:
- 在2型糖尿病肥胖患者中,与医学治疗相比,评估减肥手术的5年结果.
- 评估长期血糖控制,代谢状态,心血管风险和手术后的并发症.
- 确定通过手术程序实现的糖尿病缓解的持续时间.
主要方法:
- 一个开放的,随机的受控试验,比较Roux-en-Y胃绕道和胆转移与医疗治疗.
- 纳入标准: 肥胖患者 (BMI ≥35 kg/ m2) 患有2型糖尿病,持续时间≥5年.
- 主要终点:糖尿病缓解2年 (HbA1c ≤6. 5% 没有药物治疗1年);分析了5年后的血糖控制,代谢参数和并发症.
主要成果:
- 在5年后,50%的外科手术患者 (胃绕道37%,胆腺转移63%) 保持糖尿病缓解,而医疗患者为0% (p=0.0007).
- 与医疗管理相比,手术组的HbA1c显著改善,心血管风险降低,脂质水平降低,药物使用减少.
- 虽然手术组的体重减轻较大,但它没有预测缓解或复发;然而,手术后糖尿病严重并发症显著减少.
结论:
- 在肥胖患者中,减肥手术比医疗治疗更有效.
- 在这种患者群体的治疗算法中,应考虑进行手术.
- 由于高血糖复发的可能性,持续监测血糖控制至关重要.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
360
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
360
Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Carbohydrate Metabolism
14.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.9K
Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones
908
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
908
Diabetes Mellitus: Overview and Type I Subtype
5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K

